A program to improve lifestyle behaviors in young women with breast cancer
Efecto de Una intervención Multidisciplinaria de Estilo de Vida Sobre el Exposoma de Pacientes premenopáusicas Con cáncer de Mama Estadios I-III.
This study tests a program designed to help young women with breast cancer make healthy lifestyle changes to improve their overall well-being and treatment outcomes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 146 (estimated) |
| Ages | 18 Years to 40 Years |
| Sex | Female |
| Sponsor | Instituto Nacional de Cancerologia de Mexico Academic / other |
| Drugs / interventions | chemotherapy |
| Locations | 1 site (México) |
| Trial ID | NCT06090747 on ClinicalTrials.gov |
What this trial studies
This clinical trial evaluates a hybrid multidisciplinary intervention aimed at promoting healthy lifestyle changes among young women diagnosed with breast cancer. Participants will be randomly assigned to either a group receiving a hybrid lifestyle education intervention or a group receiving individualized hybrid lifestyle interventions. The program incorporates various disciplines, including oncology, nutrition, physiotherapy, and psychology, to address both external and internal factors affecting health outcomes. The goal is to modify the personal and internal exposome to improve treatment responses and overall well-being.
Who should consider this trial
Good fit: Ideal candidates are women diagnosed with stage I-III breast cancer who are candidates for multidisciplinary treatment.
Not a fit: Patients with inflammatory cancer or significant cardiovascular issues may not benefit from this study.
Why it matters
Potential benefit: If successful, this program could lead to improved health outcomes and quality of life for young women with breast cancer.
How similar studies have performed: Other studies have shown promising results with multidisciplinary interventions in cancer care, suggesting potential success for this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Women diagnosed with stage I-III BC, confirmed by pathology and image at the INCAN * Candidates for multidisciplinary treatment including surgery, chemotherapy, and/or hormonal treatments. * Signed the informed consent form * Have access to a mobile phone or any electronic device with an active internet connection to receive the program information. Exclusion Criteria: * Patients with inflammatory cancer * Those with cardiomyopathy or ventricular dysfunction (NYHA \>II), arrythmia secondary to left ventricular ejection alterations that requires medication, previous myocardial infarction, or angina pectoris in the last six months * Receiving treatment for cardiovascular or cerebrovascular disease, inflammatory bowel disease, malabsorption syndrome, rheumatoid arthritis, lupus, thyroid diseases, or Cushing syndrome * Unable to walk for at least 1 km * Have cardiovascular, respiratory, or musculoskeletal diseases that impede physical activity * Pregnant or breastfeeding * Have psychiatric conditions impeding active participation in this protocol * Do not understand Spanish
Where this trial is running
México
- Dr. Marlid Cruz Ramos — México, Mexico (Recruiting)
Study contacts
- Study coordinator: Marlid Cruz Ramos, PhD
- Email: marlid.cruz@gmail.com
- Phone: +525556280400
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.